CVS Health Corporation vs Centene Corporation
A head-to-head of CVS Health Corporation (CVS) and Centene Corporation (CNC) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | CVS | CNC |
|---|---|---|
| Market Cap | $137.12B | $32.81B |
| P/E (TTM) | 47.34 | — |
| Forward P/E | 12.78 | 14.60 |
| P/S | 0.29 | 0.14 |
| P/B | 2.48 | 1.52 |
| EV/EBITDA | 12.05 | 3.79 |
| Dividend Yield | 1.77% | — |
| Profit Margin | 0.72% | -3.25% |
| Gross Margin | 13.77% | 12.24% |
| Operating Margin | 2.58% | -3.91% |
| Revenue Growth (YoY) | +6.17% | +7.13% |
| FCF Yield | 6.21% | 29.17% |
| Debt / Equity | 81.29 | 77.02 |
| Current Ratio | 0.87 | 1.12 |
Which is better: CVS Health Corporation or Centene Corporation?
- ✓Larger by market cap: CVS Health Corporation
- ✓More profitable (net margin): CVS Health Corporation
- ✓Faster revenue growth: Centene Corporation
- ✓Higher free-cash-flow yield: Centene Corporation
Across 11 available metrics, Centene Corporation leads 7–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.